HOME >> BIOLOGY >> NEWS
Insulin grown in plants relieves diabetes in mice; UCF study holds promise for humans

Capsules of insulin produced in genetically modified lettuce could hold the key to restoring the bodys ability to produce insulin and help millions of Americans who suffer from insulin-dependent diabetes, according to University of Central Florida biomedical researchers.

Professor Henry Daniells research team genetically engineered tobacco plants with the insulin gene and then administered freeze-dried plant cells to five-week-old diabetic mice as a powder for eight weeks. By the end of the study, the diabetic mice had normal blood and urine sugar levels, and their cells were producing normal levels of insulin.

Those results and prior research indicate that insulin capsules could someday be used to prevent diabetes before symptoms appear and treat the disease in its later stages, Daniell said. He has since proposed using lettuce instead of tobacco to produce the insulin because that crop can be produced cheaply and avoids the negative stigma associated with tobacco.

The National Institutes of Health provided $2 million to fund the UCF study. The findings are reported in the July issue of Plant Biotechnology Journal.

Insulin-dependent, or Type 1, diabetes is an autoimmune disease in which the bodys immune system attacks and destroys insulin and insulin-producing beta cells in the pancreas. Insulin is a hormone that is needed to convert sugar, starches and other food into energy.

Insulin typically is given through shots and not pills so the hormone can go straight into the bloodstream. In Daniells method, plant cell walls made of cellulose initially prevent insulin from degrading. When the plant cells containing insulin reach the intestine, bacteria living there begin to slowly break down the cell walls and gradually release insulin into the bloodstream.

Currently, the only relief for diabetes is a momentary relief, Daniell said. Diabetics still have to monitor their blood and urine sugar levels. They
'"/>

Contact: Chad Binette
cbinette@mail.ucf.edu
407-823-6312
University of Central Florida
30-Jul-2007


Page: 1 2

Related biology news :

1. Insulin sensitizer also serves as energy-conserving signal to the brain
2. Insulin therapy shown to treat early experimental diabetic retinopathy
3. Insulin -- in need of some restraint?
4. Insulin pathway component explains insulin resistance, age-associated metabolic syndrome
5. Insulin research builds on Nobel Laureates work
6. Insulin sensitivity gets a kick out of SOCS-7
7. Insulin spares intensive care patients from organ failure and death
8. Insulin pulses keep the liver lean
9. Scientists map air pollution using corn grown in US fields
10. Neurons grown from embryonic stem cells restore function in paralyzed rats
11. UCF, NIH study: Effective, safe anthrax vaccine can be grown in tobacco plants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2020)... ... February 14, 2020 , ... ... that include integrated eTMF and Payment tracking, will be showcasing SimpleTrials at the ... , Since attending the SCOPE Summit last year, the SimpleTrials team has completed ...
(Date:2/11/2020)... ... February 11, 2020 , ... Modality Solutions, ... its ISO 9001:2015 registration by certification body Intertek. Modality Solutions’ Quality Manager, Hannah ... revised all existing Standard Operating Procedures (SOPs) and created ten new SOPs. Anderson ...
(Date:2/6/2020)... ... February 06, 2020 , ... Syntactx, ... device and pharmaceutical trials, announced that Ms. Dorothy Abel has joined the ... oversees the development and execution of regulatory plans designed to help clients ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... ... , ... Ideal Implant CEO and President Robert S Hamas, ... American investor forums specializing in medical advancements. New technology was presented to US ... November 21, 2019 in New York City, and the Aesthetic Technology Summit in ...
(Date:1/22/2020)... ... January 21, 2020 , ... QCDx , a private biotech company ... blood draw, today announced the sale of the proprietary RareScope™ instrument to the Carole ... used in clinical cancer research. , “The RareScope can detect and isolate intact and ...
(Date:1/8/2020)... ... 08, 2020 , ... Anomet Products has introduced ... use in harsh environments inside or outside of the human body. , ... alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures ...
(Date:1/7/2020)... and SOMERVILLE, Mass. (PRWEB) , ... January 06, ... ... Murrow Center for a Digital World at The Fletcher School at Tufts University, ... Alfred P. Sloan Foundation. The grant will be administered by Tufts University, and ...
Breaking Biology Technology:
Cached News: